{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:17:03Z","timestamp":1788347823542,"version":"build-2803163510"},"reference-count":69,"publisher":"American Chemical Society (ACS)","issue":"11","license":[{"start":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T00:00:00Z","timestamp":1583884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/pubs.acs.org\/page\/policy\/authorchoice_termsofuse.html"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology , Ministry of Science and Technology","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Protein aggregation and oxidative stress are two pathological hallmarks of a number of protein misfolding diseases, including Huntington\u2019s disease (HD). Whether protein aggregation precedes elevation of oxidative stress or follows it remains ambiguous. We have investigated the role of harmine, a beta-carboline alkaloid, in aggregation of a mutant huntingtin fragment (103Q-htt) in a yeast model of HD. We observed that harmine was able to decrease intracellular aggregation of 103Q-htt, and this reduction was higher than that observed with trehalose, a conventional protein stabilizer. The presence of harmine also decreased prion formation. Decreased protein aggregation was accompanied by reduction in oxidative stress. However, harmine had no effect on aggregation of the mutant huntingtin fragment in vitro. Thus, based on experimental data, we conclude that the antioxidant harmine lowers aggregation-induced elevation in oxidative stress, which slows down intracellular protein aggregation.<\/jats:p>","DOI":"10.1021\/acsomega.9b02375","type":"journal-article","created":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T04:36:12Z","timestamp":1583901372000},"page":"5620-5628","source":"Crossref","is-referenced-by-count":15,"title":["Harmine Acts as an Indirect Inhibitor\nof Intracellular Protein Aggregation"],"prefix":"10.1021","volume":"5","author":[{"given":"Swati","family":"Jain","sequence":"first","affiliation":[{"name":"National Institute of Pharmaceutical Education and Research , , Sector 67, S.A.S. Nagar , ,","place":["Punjab, India, 160062"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkataharsha","family":"Panuganti","sequence":"additional","affiliation":[{"name":"National Institute of Pharmaceutical Education and Research , , Sector 67, S.A.S. Nagar , ,","place":["Punjab, India, 160062"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Jha","sequence":"additional","affiliation":[{"name":"National Institute of Pharmaceutical Education and Research , , Sector 67, S.A.S. Nagar , ,","place":["Punjab, India, 160062"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1120-444X","authenticated-orcid":true,"given":"Ipsita","family":"Roy","sequence":"additional","affiliation":[{"name":"National Institute of Pharmaceutical Education and Research , , Sector 67, S.A.S. Nagar , ,","place":["Punjab, India, 160062"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2020,3,11]]},"reference":[{"key":"2026090206535551200_cit1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","article-title":"Huntington\u2019s disease: a clinical review","volume":"25","author":"McColgan","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"2026090206535551200_cit2","doi-asserted-by":"publisher","first-page":"a024240","DOI":"10.1101\/cshperspect.a024240","article-title":"Huntington\u2019s Disease: Mechanisms of pathogenesis\nand therapeutic strategies","volume":"7","author":"Jimenez-Sanchez","year":"2017","journal-title":"Cold Spring Harbor\nPerspect. Med."},{"key":"2026090206535551200_cit3","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/s1474-4422(17)30280-6","article-title":"Therapies\ntargeting DNA and RNA in Huntington\u2019s disease","volume":"16","author":"Wild","year":"2017","journal-title":"Lancet Neurol."},{"key":"2026090206535551200_cit4","doi-asserted-by":"publisher","first-page":"44512","DOI":"10.1074\/jbc.m111.307587","article-title":"In vitro and in vivo aggregation of a fragment of huntingtin\nprotein directly causes free radical production","volume":"286","author":"Hands","year":"2011","journal-title":"J. Biol. Chem."},{"key":"2026090206535551200_cit5","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1056\/nejmra1012478","article-title":"Monogenic mitochondrial disorders","volume":"366","author":"Koopman","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"2026090206535551200_cit6","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1093\/hmg\/dds516","article-title":"Elevated NADPH oxidase activity contributes to oxidative\nstress and cell death in Huntington\u2019s disease","volume":"22","author":"Valencia","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"2026090206535551200_cit7","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3389\/fnins.2018.00342","article-title":"Mitochondrial\nquality control in neurodegenerative diseases: Focus on Parkinson\u2019s\nDisease and Huntington\u2019s Disease","volume":"12","author":"Franco-Iborra","year":"2018","journal-title":"Front.\nNeurosci."},{"key":"2026090206535551200_cit8","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1007\/s11011-018-0308-1","article-title":"Mitochondrial\nalterations accompanied by oxidative stress conditions in skin fibroblasts\nof Huntington\u2019s disease patients","volume":"33","author":"Je\u0328drak","year":"2018","journal-title":"Metab.\nBrain Dis."},{"key":"2026090206535551200_cit9","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1021\/acs.chemrev.8b00554","article-title":"Singlet molecular oxygen reactions\nwith nucleic acids, lipids, and proteins","volume":"119","author":"Di Mascio","year":"2019","journal-title":"Chem.\nRev."},{"key":"2026090206535551200_cit10","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.freeradbiomed.2007.05.037","article-title":"Roles of amyloid\nbeta-peptide-associated oxidative stress and brain protein modifications\nin the pathogenesis of Alzheimer\u2019s disease and mild cognitive\nimpairment","volume":"43","author":"Butterfield","year":"2007","journal-title":"Free Radical Biol. Med."},{"key":"2026090206535551200_cit11","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.1007\/s12035-015-9337-5","article-title":"Oxidative stress in\nneurodegenerative diseases","volume":"53","author":"Niedzielska","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"2026090206535551200_cit12","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.freeradbiomed.2008.05.014","article-title":"Proteomic and oxidative stress analysis in human brain\nsamples of Huntington disease","volume":"45","author":"Sorolla","year":"2008","journal-title":"Free Radical\nBiol. Med."},{"key":"2026090206535551200_cit13","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.redox.2017.07.008","article-title":"Proteostasis,\noxidative stress and aging","volume":"13","author":"Korovila","year":"2017","journal-title":"Redox Biol."},{"key":"2026090206535551200_cit14","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.bbadis.2011.11.014","article-title":"Antioxidants in Huntington\u2019s disease","volume":"1822","author":"Johri","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"2026090206535551200_cit15","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/s0140-6736(14)61010-2","article-title":"Slowing of neurodegeneration in Parkinson\u2019s\ndisease and Huntington\u2019s disease: future therapeutic perspectives","volume":"384","author":"Schapira","year":"2014","journal-title":"Lancet"},{"key":"2026090206535551200_cit16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neuint.2014.12.012","article-title":"Changes in the mitochondrial\nantioxidant systems in neurodegenerative diseases and acute brain\ndisorders","volume":"88","author":"Ruszkiewicz","year":"2015","journal-title":"Neurochem. Int."},{"key":"2026090206535551200_cit17","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.neuint.2016.11.003","article-title":"Dopamine exacerbates\nmutant Huntingtin toxicity via oxidative-mediated inhibition of autophagy\nin SH-SY5Y neuroblastoma cells: Beneficial effects of anti-oxidant\ntherapeutics","volume":"101","author":"Vidoni","year":"2016","journal-title":"Neurochem. Int."},{"key":"2026090206535551200_cit18","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s12640-018-9989-9","article-title":"Protective effects of antioxidants\nin Huntington\u2019s Disease: an extensive review","volume":"35","author":"Essa","year":"2019","journal-title":"Neurotoxic. Res."},{"key":"2026090206535551200_cit19","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1002\/jcb.26536","article-title":"Neuroprotective effects of antioxidants in the management\nof neurodegenerative disorders: A literature review","volume":"120","author":"Panahi","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"2026090206535551200_cit20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/aps.2014.107","article-title":"Protopanaxtriol protects against 3-nitropropionic acid-induced\noxidative stress in a rat model of Huntington\u2019s disease","volume":"36","author":"Gao","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"2026090206535551200_cit21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134142","article-title":"Therapeutic effect of berberine on Huntington\u2019s\nDisease transgenic mouse model","volume":"10","author":"Jiang","year":"2015","journal-title":"PLoS One"},{"key":"2026090206535551200_cit22","doi-asserted-by":"publisher","first-page":"8748253","DOI":"10.1155\/2019\/8748253","article-title":"Beneficial role\nof phytochemicals on oxidative stress and age-related diseases","volume":"2019","author":"Forni","year":"2019","journal-title":"BioMed Res. Int."},{"key":"2026090206535551200_cit23","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3389\/fphar.2017.00096","article-title":"Indole alkaloids from plants as potential\nleads for antidepressant drugs: A mini review","volume":"8","author":"Hamid","year":"2017","journal-title":"Front. Pharmacol."},{"key":"2026090206535551200_cit24","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/0006-2952(91)90305-o","article-title":"Antioxidative properties of harmane\nand beta-carboline alkaloids","volume":"42","author":"Tse","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"2026090206535551200_cit25","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/mutage\/gem016","article-title":"Antioxidant properties of beta-carboline alkaloids are related to\ntheir antimutagenic and antigenotoxic activities","volume":"22","author":"Moura","year":"2007","journal-title":"Mutagenesis"},{"key":"2026090206535551200_cit26","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.foodchem.2014.09.091","article-title":"Hydroxyl radical reactions and the radical scavenging\nactivity of \u03b2-carboline alkaloids","volume":"172","author":"Herraiz","year":"2015","journal-title":"Food\nChem."},{"key":"2026090206535551200_cit27","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1046\/j.1471-4159.2000.0750521.x","article-title":"Protective effect of harmalol and\nharmaline on MPTP neurotoxicity in the mouse and dopamine-induced\ndamage of brain mitochondria and PC12 cells","volume":"75","author":"Lee","year":"2002","journal-title":"J. Neurochem."},{"key":"2026090206535551200_cit28","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1211\/jpp.58.7.0012","article-title":"Protective effects of Peganum harmalal.\nextract, harmine and harmaline against human low-density lipoprotein\noxidation","volume":"58","author":"Berrougui","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"2026090206535551200_cit29","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s00702-010-0451-2","article-title":"Chronic administration of harmine\nelicits antidepressant-like effects and increases BDNF levels in rat\nhippocampus","volume":"117","author":"Fortunato","year":"2010","journal-title":"J. Neural Transm."},{"key":"2026090206535551200_cit30","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nrd3366","article-title":"Potential therapeutic uses of BDNF in neurological\nand psychiatric disorders","volume":"10","author":"Nagahara","year":"2011","journal-title":"Nat. Rev. Drug Discovery"},{"key":"2026090206535551200_cit31","doi-asserted-by":"publisher","first-page":"4810394","DOI":"10.1155\/2018\/4810394","article-title":"Monoamine oxidase-A inhibition and associated antioxidant\nactivity in plant extracts with potential antidepressant actions","volume":"2018","author":"Herraiz","year":"2018","journal-title":"BioMed Res. Int."},{"key":"2026090206535551200_cit32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.pharmthera.2015.03.004","article-title":"DYRK1A in neurodegeneration\nand cancer: Molecular basis and clinical implications","volume":"151","author":"Abbassi","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"2026090206535551200_cit33","doi-asserted-by":"publisher","first-page":"6544","DOI":"10.1073\/pnas.0910200107","article-title":"Systematic discovery\nof nonobvious human disease models through orthologous phenotypes","volume":"107","author":"McGary","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2026090206535551200_cit34","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.mad.2016.05.002","article-title":"Yeast buddies helping to unravel the complexity of\nneurodegenerative disorders","volume":"161","author":"Fruhmann","year":"2017","journal-title":"Mech. Ageing Dev."},{"key":"2026090206535551200_cit35","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3389\/fnmol.2018.00318","article-title":"Studying Huntington\u2019s\nDisease in yeast: From mechanisms to pharmacological approaches","volume":"11","author":"Hofer","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"2026090206535551200_cit36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1042\/bse0560085","article-title":"Yeast models for amyloid disease","volume":"56","author":"Panaretou","year":"2014","journal-title":"Essays Biochem."},{"key":"2026090206535551200_cit37","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1083\/jcb.200112104","article-title":"Huntingtin toxicity in yeast model\ndepends on polyglutamine aggregation mediated by a prion-like protein\nRnq1","volume":"157","author":"Meriin","year":"2002","journal-title":"J. Cell Biol."},{"key":"2026090206535551200_cit38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044785","article-title":"Aggregation of polyQ proteins is increased upon yeast\naging and affected by Sir2 and Hsf1: novel quantitative biochemical\nand microscopic assays","volume":"7","author":"Cohen","year":"2012","journal-title":"PLoS One"},{"key":"2026090206535551200_cit39","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1038\/mt.2015.157","article-title":"Inhibition\nof aggregation of mutant huntingtin by nucleic acid aptamers in vitro\nand in a yeast model of Huntington\u2019s disease","volume":"23","author":"Chaudhary","year":"2015","journal-title":"Mol. Ther."},{"key":"2026090206535551200_cit40","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1073\/pnas.97.4.1589","article-title":"Aggregation\nof huntingtin in yeast varies with the length of the polyglutamine\nexpansion and the expression of chaperone proteins","volume":"97","author":"Krobitsch","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2026090206535551200_cit41","first-page":"143","article-title":"Trehalose as a \u201cchemical chaperone\u201d:\nfact and fantasy","volume-title":"Advances in Experimental\nMedicine and Biology","author":"Crowe","year":"2007"},{"key":"2026090206535551200_cit42","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/pro.3","article-title":"Effect of trehalose on protein structure","volume":"18","author":"Jain","year":"2009","journal-title":"Protein\nSci."},{"key":"2026090206535551200_cit43","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s12017-013-8275-5","article-title":"Deciphering\nthe roles of trehalose and Hsp104 in the inhibition of aggregation\nof mutant huntingtin in a yeast model of Huntington\u2019s disease","volume":"16","author":"Chaudhary","year":"2014","journal-title":"NeuroMol. Med."},{"key":"2026090206535551200_cit44","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/bph.14623","article-title":"Trehalose\nas a promising therapeutic candidate for the treatment of Parkinson\u2019s\ndisease","volume":"176","author":"Khalifeh","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"2026090206535551200_cit45","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nm985","article-title":"Trehalose alleviates polyglutamine-mediated\npathology in a mouse model of Huntington disease","volume":"10","author":"Tanaka","year":"2004","journal-title":"Nat. Med."},{"key":"2026090206535551200_cit46","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/s0092-8674(00)80514-0","article-title":"Huntingtin-encoded polyglutamine\nexpansions form amyloid-like protein aggregates in vitro and in vivo","volume":"90","author":"Scherzinger","year":"1997","journal-title":"Cell"},{"key":"2026090206535551200_cit47","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.freeradbiomed.2014.02.028","article-title":"Pathophysiological\nimportance of aggregated damaged proteins","volume":"71","author":"Ho\u0308hn","year":"2014","journal-title":"Free\nRadical Biol. Med."},{"key":"2026090206535551200_cit48","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1007\/s12035-018-1334-z","article-title":"Cellular proteostasis in neurodegeneration","volume":"56","author":"Kurtishi","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"2026090206535551200_cit49","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1042\/bj20121806","article-title":"Hsp104 as a key modulator of prion-mediated oxidative stress in Saccharomyces\ncerevisiae","volume":"454","author":"Singh","year":"2013","journal-title":"Biochem. J."},{"key":"2026090206535551200_cit50","doi-asserted-by":"publisher","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev.\nDis. Primers"},{"key":"2026090206535551200_cit51","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/1531-8249(200001)47:1&lt;80::aid-ana13&gt;3.0.co;2-k","article-title":"Mitochondrial\ndysfunction and free radical damage in the Huntington R6\/2 transgenic\nmouse","volume":"47","author":"Tabrizi","year":"2000","journal-title":"Ann. Neurol."},{"key":"2026090206535551200_cit52","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1096\/fj.09-148601","article-title":"Suppression\nof polyglutamine-induced cytotoxicity in Saccharomyces cerevisiae\nby enhancement of mitochondrial biogenesis","volume":"24","author":"Ocampo","year":"2010","journal-title":"FASEB J."},{"key":"2026090206535551200_cit53","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.freeradbiomed.2013.04.017","article-title":"Role of oxidative\nDNA damage in mitochondrial dysfunction and Huntington\u2019s disease\npathogenesis","volume":"62","author":"Ayala-Pen\u0303a","year":"2013","journal-title":"Free Radical Biol. Med."},{"key":"2026090206535551200_cit54","doi-asserted-by":"publisher","first-page":"6512","DOI":"10.1002\/anie.201811122","article-title":"Dopamine, oxidative stress and protein-quinone\nmodifications in Parkinson\u2019s and other neurodegenerative diseases","volume":"58","author":"Monzani","year":"2019","journal-title":"Angew. Chem., Int. Ed. Engl."},{"key":"2026090206535551200_cit55","doi-asserted-by":"publisher","first-page":"7841","DOI":"10.1073\/pnas.140202897","article-title":"Hsp70 and hsp40\nchaperones can inhibit self-assembly of polyglutamine proteins into\namyloid-like fibrils","volume":"97","author":"Muchowski","year":"2000","journal-title":"Proc. Natl. Acad. Sci.\nU.S.A."},{"key":"2026090206535551200_cit56","doi-asserted-by":"publisher","first-page":"13201","DOI":"10.1073\/pnas.191498198","article-title":"Altered transcription in yeast expressing\nexpanded polyglutamine","volume":"98","author":"Hughes","year":"2001","journal-title":"Proc. Natl. Acad. Sci.\nU.S.A."},{"key":"2026090206535551200_cit57","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.molcel.2004.06.029","article-title":"Cellular toxicity of polyglutamine expansion proteins:\nmechanism of transcription factor deactivation","volume":"15","author":"Schaffar","year":"2004","journal-title":"Mol. Cell"},{"key":"2026090206535551200_cit58","doi-asserted-by":"publisher","first-page":"11045","DOI":"10.1073\/pnas.0604547103","article-title":"Flanking sequences profoundly alter polyglutamine toxicity\nin yeast","volume":"103","author":"Duennwald","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2026090206535551200_cit59","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s12035-012-8252-2","article-title":"Effect of pesticides on the aggregation\nof mutant huntingtin protein","volume":"45","author":"Deshmukh","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"2026090206535551200_cit60","doi-asserted-by":"publisher","first-page":"9843","DOI":"10.1074\/jbc.274.14.9843","article-title":"Both familial Parkinson\u2019s disease mutations\naccelerate alpha-synuclein aggregation","volume":"274","author":"Narhi","year":"1999","journal-title":"J. Biol.\nChem."},{"key":"2026090206535551200_cit61","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/ana.10277","article-title":"A meta-analysis\nof coffee drinking, cigarette smoking, and the risk of Parkinson\u2019s\ndisease","volume":"52","author":"Herna\u0301n","year":"2002","journal-title":"Ann. Neurol."},{"key":"2026090206535551200_cit62","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/mds.27577","article-title":"The association between lifestyle factors and Parkinson\u2019s\ndisease progression and mortality","volume":"34","author":"Paul","year":"2019","journal-title":"Mov. Disord."},{"key":"2026090206535551200_cit63","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1021\/acschemneuro.5b00158","article-title":"Understanding caffeine\u2019s role in attenuating the toxicity\nof \u03b1-synuclein aggregates: Implications for risk of Parkinson\u2019s\nDisease","volume":"6","author":"Kardani","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"2026090206535551200_cit64","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.bbadis.2017.02.002","article-title":"Nicotine slows\ndown oligomerisation of alpha-synuclein and ameliorates cytotoxicity\nin a yeast model of Parkinson\u2019s disease","volume":"1863","author":"Kardani","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"2026090206535551200_cit65","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1093\/nar\/20.6.1425","article-title":"Improved method for high efficiency transformation\nof intact yeast cells","volume":"20","author":"Gietz","year":"1992","journal-title":"Nucleic Acids Res."},{"key":"2026090206535551200_cit66","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1006\/prep.2001.1595","article-title":"Expression and purification of homogenous proteins\nin Saccharomyces cerevisiae based on ubiquitin-FLAG fusion","volume":"24","author":"Einhauer","year":"2002","journal-title":"Protein Expression Purif."},{"key":"2026090206535551200_cit67","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for\nthe quantitation of microgram quantities of protein utilizing the\nprinciple of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"2026090206535551200_cit68","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1089\/ars.2012.4886","article-title":"Methods for detection of mitochondrial and cellular\nreactive oxygen species","volume":"20","author":"Dikalov","year":"2014","journal-title":"Antioxid. Redox Signaling"},{"key":"2026090206535551200_cit69","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/s0731-7085(02)00568-x","article-title":"HPLC method for the analysis of harmol,\nharmalol, harmine and harmaline in the seeds of Peganum harmala L","volume":"31","author":"Kartal","year":"2003","journal-title":"J. Pharm. Biomed. Anal."}],"container-title":["ACS Omega"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsomega.9b02375","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/acsodf\/article-pdf\/5\/11\/5620\/67697171\/acsomega.9b02375.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/acsodf\/article-pdf\/5\/11\/5620\/67697171\/acsomega.9b02375.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:54:03Z","timestamp":1788346443000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/acsodf\/article\/5\/11\/5620\/1400306\/Harmine-Acts-as-an-Indirect-Inhibitor-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,11]]},"references-count":69,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,3,11]]},"published-print":{"date-parts":[[2020,3,24]]}},"URL":"https:\/\/doi.org\/10.1021\/acsomega.9b02375","relation":{},"ISSN":["2470-1343"],"issn-type":[{"value":"2470-1343","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,11]]}}}